Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model
- PMID: 19728973
- PMCID: PMC2739085
Coregistration of ultrasonography and magnetic resonance imaging with a preliminary investigation of the spatial colocalization of vascular endothelial growth factor receptor 2 expression and tumor perfusion in a murine tumor model
Abstract
We present an ultrasonography (US)-magnetic resonance imaging (MRI) coregistration technique and examine its application in a preliminary multimodal, multiparametric study in a preclinical model of breast cancer. Nine mice were injected with 67NR breast cancer cells and imaged 6 and 9 days later with 4.7 T MRI and high-frequency US. Tumor volumes from each data set were segmented independently by two investigators and coregistered using an iterative closest point algorithm. In addition to anatomic images, vascular endothelial growth factor receptor 2 (VEGFR2) distribution images from the central tumor slice using VEGFR2-targeted ultrasound contrast agent (UCA) and measurements of perfusion and extravascular-extracellular volume fraction using dynamic contrast-enhanced MRI were acquired from five mice for multiparametric coregistration. Parametric maps from each modality were coregistered and examined for spatial correlation. Average registration root mean square (RMS) error was 0.36 +/- 0.11 mm, less than approximately two voxels. Segmented volumes were compared between investigators to minimize interobserver variability; the average RMS error was 0.23 +/- 0.09 mm. In the preliminary study, VEGFR2-targeted UCA data did not demonstrate direct spatial correlation with magnetic resonance measures of vascular properties. In summary, a method for accurately coregistering small animal US and MRI has been presented that allows for comparison of quantitative metrics provided by the two modalities.
Figures
Similar articles
-
Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model.J Ultrasound Med. 2008 Jun;27(6):855-66. doi: 10.7863/jum.2008.27.6.855. J Ultrasound Med. 2008. PMID: 18499845
-
Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography.J Ultrasound Med. 2007 Nov;26(11):1575-86. doi: 10.7863/jum.2007.26.11.1575. J Ultrasound Med. 2007. PMID: 17957052 Free PMC article.
-
US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.Radiology. 2008 Feb;246(2):508-18. doi: 10.1148/radiol.2462070536. Epub 2008 Jan 7. Radiology. 2008. PMID: 18180339 Free PMC article.
-
Molecular Ultrasound Imaging.Recent Results Cancer Res. 2020;216:509-531. doi: 10.1007/978-3-030-42618-7_15. Recent Results Cancer Res. 2020. PMID: 32594397 Review.
-
Application of magnetic resonance imaging to angiogenesis in breast cancer.Breast Cancer Res. 2001;3(1):22-7. doi: 10.1186/bcr266. Breast Cancer Res. 2001. PMID: 11300102 Free PMC article. Review.
Cited by
-
Bioluminescence imaging of angiogenesis in a murine orthotopic pancreatic cancer model.Mol Imaging Biol. 2010 Dec;12(6):570-5. doi: 10.1007/s11307-010-0310-4. Mol Imaging Biol. 2010. PMID: 20376570 Free PMC article.
-
Janus USPION modular platform (JUMP) for theranostic ultrasound-mediated targeted intratumoral microvascular imaging and DNA/miRNA delivery.Theranostics. 2022 Nov 7;12(18):7646-7667. doi: 10.7150/thno.78454. eCollection 2022. Theranostics. 2022. PMID: 36451861 Free PMC article.
-
Comparison of dynamic contrast-enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF-03084014 and sunitinib.Cancer Med. 2014 Jun;3(3):462-71. doi: 10.1002/cam4.215. Epub 2014 Feb 27. Cancer Med. 2014. PMID: 24573979 Free PMC article.
-
Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights.Biomedicines. 2024 Apr 9;12(4):827. doi: 10.3390/biomedicines12040827. Biomedicines. 2024. PMID: 38672182 Free PMC article. Review.
-
Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma.J Invest Dermatol. 2011 Dec;131(12):2467-76. doi: 10.1038/jid.2011.300. Epub 2011 Sep 22. J Invest Dermatol. 2011. PMID: 21938011 Free PMC article.
References
-
- Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182–6. - PubMed
-
- Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442–7. - PubMed
-
- Hsu AR, Chen X. Advances in anatomic, functional, and molecular imaging of angiogenesis. J Nucl Med. 2008;49:511–4. - PubMed
-
- Barrett T, Brechbiel M, Bernardo M, Choyke PL. MRI of tumor angiogenesis. J Magn Reson Imaging. 2007;26:235–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources